Corbus Pharmaceuticals Holdings, Inc.

UBS Group AG CRBP

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/8/2023

29,956

Value ($000)

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/8/2023	3	0.0%	29,956	12/31/2022
2022 Q3	11/10/2022	7	0.0%	42,504	9/30/2022
2022 Q2	8/10/2022	0	0.0%	1,951	6/30/2022
2022 Q1	5/16/2022	11	0.0%	21,379	3/31/2022
2021 Q4	2/14/2022	24	0.0%	38,580	12/31/2021
2021 Q3	11/15/2021	12	0.0%	10,712	9/30/2021
2021 Q2	8/13/2021	33	0.0%	17,825	6/30/2021
2021 Q1	5/12/2021	39	0.0%	19,668	3/31/2021
2020 Q4	2/11/2021	4	0.0%	3,463	12/31/2020
2020 Q3	11/12/2020	7	0.0%	3,979	9/30/2020
2020 Q2	7/31/2020	1,461	0.0%	174,082	6/30/2020
2020 Q1	5/1/2020	214	0.0%	40,748	3/31/2020
2019 Q4	2/14/2020	476	0.0%	87,142	12/31/2019